HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Kato, M. Search for Related Content PubMed PubMed Citation Articles by Kato, M.

In Vivo Labeling of Red Blood Cells with Tc-99m with Stannous Pyridoxylideneaminates

Nihon Medi-Physics Co., Ltd., Takarazuka, Japan

Correspondence: For reprints contact: Makoto Kato, Technical Dept., Nihon Medi-Physics Co., Ltd., 4, 2–1, Takatsukasa, Takarazuka, Hyogo, Japan 665.

ABSTRACT

Several stannous pyridoxylideneaminates were evaluated as stannous ion sources for the in vivo labeling of red blood cells (RBCs) with Tc-99m. In spite of a considerable variety of stannous preparations, rapid and efficient RBC labeling was obtained with each stannous chelate. These results suggest that the role of the ligands is merely to stabilize the divalent state of the tin. The optimal time interval between Sn(II) and ^99mTcO^–₄ injections, and the best stannous-ion concentration, was found using stannous pyridoxylideneisoleucine (Sn-P.isoL). Maximal in vivo labeling of the RBCs was obtained with an i.v. dose of 10–20 µg Sn(II)/kg of Sn-P.isoL followed 15–30 min later by i.v administration of pertechnetate.